The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
nITRO: A phase 2 study of perioperative liposomal irinotecan + 5-fluorouracil/leucovorin + oxaliplatin (NALIRIFOX) in patients with resectable pancreatic ductal adenocarcinoma (rPDAC).
 
Davide Melisi
Consulting or Advisory Role - Baxter; Evotec; Incyte; iOnctura; Lilly
Research Funding - Celgene; Incyte; iOnctura; Roche; Shire
 
Camilla Zecchetto
No Relationships to Disclose
 
Valeria Merz
No Relationships to Disclose
 
Giuseppe Malleo
Consulting or Advisory Role - Oncosil
Research Funding - FibroGen
 
Luca Landoni
No Relationships to Disclose
 
Alberto Quinzii
No Relationships to Disclose
 
Simona Casalino
No Relationships to Disclose
 
Marina Gaule
No Relationships to Disclose
 
Camilla Pesoni
No Relationships to Disclose
 
Luca Casetti
No Relationships to Disclose
 
Alessandro Esposito
No Relationships to Disclose
 
Cristiana Piazzola
No Relationships to Disclose
 
Mirko D'Onofrio
Honoraria - Bracco Diagnostics; Hitachi; Novartis; Siemens Healthcare Diagnostics
 
Riccardo de Robertis
Honoraria - Bracco Diagnostics; Fujifilm
Travel, Accommodations, Expenses - Bracco Diagnostics; Fujifilm
 
Armando Gabbrielli
No Relationships to Disclose
 
Claudio Luchini
No Relationships to Disclose
 
Giovanni Butturini
No Relationships to Disclose
 
Aldo Scarpa
Consulting or Advisory Role - Incyte
Speakers' Bureau - Amgen; GlaxoSmithKline/Tesaro; MSD
 
Roberto Salvia
No Relationships to Disclose
 
Claudio Bassi
No Relationships to Disclose